Goldman Sachs
PVCT

Goldman Sachs’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-153,020
Closed -$15K 4716
2016
Q3
$15K Sell
153,020
-46,213
-23% -$4.53K ﹤0.01% 4474
2016
Q2
$74K Buy
199,233
+60,559
+44% +$22.5K ﹤0.01% 4194
2016
Q1
$53K Sell
138,674
-232,060
-63% -$88.7K ﹤0.01% 4209
2015
Q4
$145K Sell
370,734
-591,286
-61% -$231K ﹤0.01% 3862
2015
Q3
$553K Buy
+962,020
New +$553K ﹤0.01% 3241
2015
Q1
Sell
-14,900
Closed -$12K 4729
2014
Q4
$12K Sell
14,900
-277,951
-95% -$224K ﹤0.01% 4510
2014
Q3
$299K Sell
292,851
-11,538
-4% -$11.8K ﹤0.01% 3659
2014
Q2
$262K Buy
+304,389
New +$262K ﹤0.01% 3811